Evidence map›Paper›PMID 32681259›Full record

ArticleCurrent medical science2020

The Role of Ankaferd Blood Stopper and Oxytocin as Potential Therapeutic Agents in Endometriosis: A Rat Model.

Ismet Hortu, Gokay Ozceltik, Elif Karadadas, Oytun Erbas, Gurkan Yigitturk, Murat Ulukus

Abstract read
PubMed Publisher
In one paragraph

Article in Current medical science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Effects of Breastfeeding on Endometriosis-Related Pain: A Prospective Observational Study.International journal of environmental research and public health · 2021
    Observational
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ismet HortuDepartment of Obstetrics and Gynecology, School of Medicine, Ege University, Izmir, 35100, Turkey. ismethortu@yahoo.com.
Gokay OzceltikDepartment of Obstetrics and Gynecology, School of Medicine, Ege University, Izmir, 35100, Turkey.
Elif KaradadasDepartment of Biochemistry, School of Medicine, Ege University, Izmir, 35100, Turkey.
Oytun ErbasDepartment of Physiology, School of Medicine, Istanbul Bilim University, Istanbul, 34394, Turkey.
Gurkan YigitturkDepartment of Histology and Embryology, School of Medicine, Mugla Sitki Kocman University, Mugla, 48000, Turkey.
Murat UlukusDepartment of Obstetrics and Gynecology, School of Medicine, Ege University, Izmir, 35100, Turkey.
Ege University · TRIstanbul Bilim University · TRMuğla University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To evaluate the potential effect of Ankaferd Blood Stopper (ABS) and oxytocin (OT) in an experimental endometriosis model, 18 female Sprague Dawley rats were used in this study. The animals were divided randomly into three groups after surgical induction of endometriosis: group 1: control group (isotonic NaCl, 1 mL/kg/day, intramuscular, n=6); group 2: OT group (OT, 80 U/kg/day, intramuscular, n=6); group 3: ABS group (ABS, 1.5 mL/kg/day, intraperitoneal, n=6). Each group was treated for four weeks (two times per week). Volumes of endometriotic explants were measured in biopsy samples for histopathological analysis. Vascular endothelial growth factor (VEGF), monocyte chemotactic protein-1 (MCP-1), and tumour necrosis factor (TNF-α) levels were measured in plasma and peritoneal fluid. Endometriotic explant volumes were significantly decreased after OT administration (P<0.0001). The epithelial score was significantly decreased in both treatment groups compared to the control group (P<0.05). TUNEL immunohistochemistry showed more apoptotic changes in the endometriosis foci (gland epithelium and surrounding tissue) in the OT group than in the control group (P<0.05). The levels of VEGF, MCP-1, and TNF-α were significantly reduced in the OT group (P<0.05), whereas no significant changes in protein levels were found in the ABS-applied group. The results indicate that OT has greater potential as a therapeutic agent in experimentally induced peritoneal endometriosis, where ABS, which is a VEGF modulator, appears to act through different mechanisms to show its palliative effects on a rat model of peritoneal endometriosis.

Indexed as

AnimalsChemokine CCL2Disease Models, AnimalEndometriosisFemaleOxytocinPlant ExtractsRatsRats, Sprague-DawleyTumor Necrosis Factor-alphaVascular Endothelial Growth Factor Aankaferd blood stopperChemokine CCL2OxytocinPlant ExtractsTumor Necrosis Factor-alphaVascular Endothelial Growth Factor AAnkaferd Blood Stoppercytokinesendometriosisoxytocin

Identifiers

PMID32681259
OpenAlexW3042550680

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.